Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia.
Base Sequence
Betacoronavirus
/ genetics
COVID-19
COVID-19 Testing
COVID-19 Vaccines
Clinical Laboratory Techniques
Colombia
/ epidemiology
Coronavirus Infections
/ diagnosis
Genetic Variation
Genome, Viral
High-Throughput Nucleotide Sequencing
Humans
Molecular Epidemiology
Open Reading Frames
Pandemics
Pneumonia, Viral
/ diagnosis
RNA, Viral
/ genetics
Real-Time Polymerase Chain Reaction
/ methods
SARS-CoV-2
Sequence Alignment
Viral Proteins
/ genetics
COVID-19 diagnostic testing
Genetic diversity
Next-generation sequencing
RT-PCR
SARS-CoV-2
Journal
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
ISSN: 1567-7257
Titre abrégé: Infect Genet Evol
Pays: Netherlands
ID NLM: 101084138
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
27
05
2020
accepted:
31
05
2020
pubmed:
9
6
2020
medline:
3
10
2020
entrez:
8
6
2020
Statut:
ppublish
Résumé
The COVID-19 pandemic caused by SARS-CoV-2 is a public health problem unprecedented in the recent history of humanity. Different in-house real-time RT-PCR (rRT-PCR) methods for SARS-CoV-2 diagnosis and the appearance of genomes with mutations in primer regions have been reported. Hence, whole-genome data from locally-circulating SARS-CoV-2 strains contribute to the knowledge of its global variability and the development and fine tuning of diagnostic protocols. To describe the genetic variability of Colombian SARS-CoV-2 genomes in hybridization regions of oligonucleotides of the main in-house methods for SARS-CoV-2 detection, RNA samples with confirmed SARS-CoV-2 molecular diagnosis were processed through next-generation sequencing. Primers/probes sequences from 13 target regions for SARS-CoV-2 detection suggested by 7 institutions and consolidated by WHO during the early stage of the pandemic were aligned with Muscle tool to assess the genetic variability potentially affecting their performance. Finally, the corresponding codon positions at the 3' end of each primer, the open reading frame inspection was identified for each gene/protein product. Complete SARS-CoV-2 genomes were obtained from 30 COVID-19 cases, representative of the current epidemiology in the country. Mismatches between at least one Colombian sequence and five oligonucleotides targeting the RdRP and N genes were observed. The 3' end of 4 primers aligned to the third codon position, showed high risk of nucleotide substitution and potential mismatches at this critical position. Genetic variability was detected in Colombian SARS-CoV-2 sequences in some of the primer/probe regions for in-house rRT-PCR diagnostic tests available at WHO COVID-19 technical guidelines; its impact on the performance and rates of false-negative results should be experimentally evaluated. The genomic surveillance of SARS-CoV-2 is highly recommended for the early identification of mutations in critical regions and to issue recommendations on specific diagnostic tests to ensure the coverage of locally-circulating genetic variants.
Identifiants
pubmed: 32505692
pii: S1567-1348(20)30221-5
doi: 10.1016/j.meegid.2020.104390
pmc: PMC7272177
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Covid-19 aAPC vaccine
0
RNA, Viral
0
Viral Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
104390Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that there is no conflict of interest in the manuscript.
Références
Bull World Health Organ. 2016 Dec 1;94(12):880-892
pubmed: 27994281
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
Front Cell Infect Microbiol. 2019 Nov 12;9:382
pubmed: 31781517
JAMA. 2019 Mar 5;321(9):893-894
pubmed: 30763433
J Virol. 2010 Oct;84(19):9733-48
pubmed: 20660197
Methods. 2009 Sep;49(1):32-41
pubmed: 19477279
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Nat Med. 2020 Apr;26(4):450-452
pubmed: 32284615
J Infect. 2020 Aug;81(2):318-356
pubmed: 32325130
Curr Biol. 2020 Apr 6;30(7):1346-1351.e2
pubmed: 32197085
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Clin Chem. 2020 Apr 1;66(4):549-555
pubmed: 32031583
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147